The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is
uncertain. We investigated whether persistently negative D-dimers in patients with vein …

Patients who have a first episode of venous thromboembolism (VTE) have an elevated risk
of a recurrent episode, and this necessitates secondary prophylaxis. Anticoagulant therapy …

The post thrombotic syndrome (PTS) refers to clinical manifestations of chronic venous
insufficiency (CVI) following a deep-vein thrombosis (DVT). PTS is the most frequent …

This article has been corrected. The original version (PDF) is appended to this article as a
supplement. Background: In patients with a first unprovoked venous thromboembolism …

Background: The optimal duration of oral anticoagulant therapy in patients with deep venous
thrombosis (DVT) of the lower extremities remains uncertain. Objective: To assess whether …

Men have a higher risk of first and recurrent venous thrombosis than do women. However,
the pathophysiology underlying this phenomenon is as yet unknown. In this review article …

Venous thromboembolism (VTE) is a multifactorial disease. Major provoking factors (eg
surgery, cancer, major trauma, and immobilisation) are identified in 50–60% of patients …

Rationale: There is a lack of information on the long-term prognosis of patients with acute
pulmonary embolism (PE). Objectives: To assess the long-term risk for adverse events after …

The most important decision in the long-term treatment of venous thromboembolism (VTE) is
how long to anticoagulate. VTE provoked by a reversible risk factor, or a first unprovoked …

Background—The risk of recurrent venous thrombosis is 2-fold higher in men than in
women. In contrast, no such sex difference in the risk of first venous thrombosis has been …